{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:16Z","timestamp":1780124476051,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cystic fibrosis (CF) is a genetic disorder with significant physical and psychological impacts. CFTR modulators (CFTRm) have transformed CF care. Although CFTRm have transformed CF care, genetic eligibility creates distinct patient experiences. This study evaluates the psychological impact of genetic CFTRm eligibility status on children with CF and their caregivers. This cross-sectional study included 118 children with CF and their primary caregivers. Psychological assessments were performed by the child psychiatry team. Children completed the Child Attitude Toward Illness Scale (CATIS), Brief Illness Perception Questionnaire (BIPQ-Patient), and Children\u2019s Hope Scale (CHS). Caregivers completed the Beck Hopelessness Scale (BHS), Strengths and Difficulties Questionnaire (SDQ), and BIPQ-Caregiver. Clinical and demographic data were collected, and analyses were stratified according to CFTRm genetic eligibility and the presence of bronchiectasis. Among participants, 53.39% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200963) were genetically eligible for CFTRm, while only 35.59% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200942) were actively receiving treatment. Genetically eligible children demonstrated higher levels of hope and a more positive perception of their illness compared with genetically ineligible children. Among patients without bronchiectasis, psychological outcomes did not differ between eligibility groups. In contrast, among those with bronchiectasis, modulator-eligible children reported greater hope and more positive attitudes toward their disease, and their mothers also reported higher levels of hope.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    :\u00a0Genetic eligibility for CFTRm is associated with meaningful differences in psychological well-being among children with CF, particularly in those with more advanced lung disease. These findings suggest that eligibility status itself may function as a psychosocial determinant and should be considered when delivering patient-centered care for children with CF and their families.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>CF is associated with increased psychological burden in both children and their caregivers.<\/jats:italic>\n                              \u2022\u00a0\n                              <jats:italic>Although CFTR modulators have transformed cystic fibrosis care, access remains limited, and real-world use may be affected by factors such as genetic eligibility, treatment adherence, and potential adverse effects.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\u00a0\n                              <jats:italic>Children with CF who are genetically eligible for CFTR modulator therapy\u2014particularly those with advanced lung disease\u2014report higher levels of hope, more positive attitudes toward their illness, and lower perceived illness threat than ineligible peers.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06929-z","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:30:16Z","timestamp":1776223816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological impact of genetic eligibility for CFTR modulator therapy in children with cystic fibrosis and their parents\u00a0"],"prefix":"10.1007","volume":"185","author":[{"given":"Berrak","family":"Oztosun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simay Buse","family":"Gulumser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defne","family":"Altug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak","family":"Gunal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Anac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Cokugras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Dogangun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Ayzit","family":"Kilinc Sakalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"21","key":"6929_CR1","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","volume":"329","author":"T Ong","year":"2023","unstructured":"Ong T, Ramsey BW (2023) Cystic fibrosis: a review. JAMA 329(21):1859\u20131871. https:\/\/doi.org\/10.1001\/jama.2023.8120","journal-title":"JAMA"},{"issue":"3","key":"6929_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1183\/20734735.007516","volume":"12","author":"M Redondo","year":"2016","unstructured":"Redondo M, Keyt H, Dhar R, Chalmers JD (2016) Global impact of bronchiectasis and cystic fibrosis. Breathe 12(3):222\u2013235. https:\/\/doi.org\/10.1183\/20734735.007516","journal-title":"Breathe"},{"issue":"12","key":"6929_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","volume":"69","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, Goldbeck L, Abbott J et al (2014) Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the International Depression Epidemiological Study across nine countries. Thorax 69(12):1090\u20131097. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-205983","journal-title":"Thorax"},{"issue":"10408","key":"6929_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","volume":"402","author":"JL Taylor-Cousar","year":"2023","unstructured":"Taylor-Cousar JL, Robinson PD, Shteinberg M, Downey DG (2023) CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis. Lancet 402(10408):1171\u20131184. https:\/\/doi.org\/10.1016\/S0140-6736(23)01609-4","journal-title":"Lancet"},{"key":"6929_CR5","doi-asserted-by":"publisher","unstructured":"Zampoli M, Morrow BM and Paul G (2023) Real-world disparities and ethical considerations with access to CFTR modulator drugs: mind the gap!. Front. Pharmacol. 14:1163391. https:\/\/doi.org\/10.3389\/fphar.2023.1163391 CFF\u00a0(2022).\u00a0Cystic Fibrosis Foundation annual data report.\u00a0Available at: https:\/\/www.cff.org\/media\/38406\/download?inline","DOI":"10.3389\/fphar.2023.1163391"},{"issue":"5","key":"6929_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","volume":"38","author":"R Goodman","year":"1997","unstructured":"Goodman R (1997) The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 38(5):581\u2013586. https:\/\/doi.org\/10.1111\/j.1469-7610.1997.tb01545.x","journal-title":"J Child Psychol Psychiatry"},{"key":"6929_CR7","unstructured":"G\u00fcvenir T, \u00d6zbek A, Baykara B, Arkar H, \u015eent\u00fcrk B. ve \u0130nceka\u015f S (2008) G\u00fc\u00e7ler ve G\u00fc\u00e7l\u00fckler Anketi\u2019nin (GGA) T\u00fcrk\u00e7e uyarlamas\u0131n\u0131n psikometrik \u00f6zellikleri.\u00a0\u00c7ocuk ve Gen\u00e7lik Ruh Sa\u011fl\u0131\u011f\u0131 Dergisi 15(2), 65\u201374"},{"issue":"4","key":"6929_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/jpepsy\/18.4.467","volume":"18","author":"JK Austin","year":"1993","unstructured":"Austin JK, Huberty TJ (1993) Development of the child attitude toward illness scale. J Pediatr Psychol 18(4):467\u201380. https:\/\/doi.org\/10.1093\/jpepsy\/18.4.467","journal-title":"J Pediatr Psychol"},{"key":"6929_CR9","unstructured":"Ersun A (2010)\u00a0\u00c7ocu\u011fun kendi hastal\u0131\u011f\u0131na y\u00f6nelik tutumu \u00f6l\u00e7e\u011fi T\u00fcrk\u00e7e formu ge\u00e7erlik ve g\u00fcvenirlik \u00e7al\u0131\u015fmas\u0131\u00a0(Y\u00fcksek lisans tezi). Ege \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Enstit\u00fcs\u00fc, \u0130zmir"},{"issue":"3","key":"6929_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/08870449608400270","volume":"11","author":"J Weinman","year":"1996","unstructured":"Weinman J, Petrie KJ, Moss-morris R, Horne R (1996) The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 11(3):431\u2013445. https:\/\/doi.org\/10.1080\/08870449608400270","journal-title":"Psychol Health"},{"issue":"1","key":"6929_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870440290001494","volume":"17","author":"R Moss-Morris","year":"2002","unstructured":"Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D (2002) The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 17(1):1\u201316. https:\/\/doi.org\/10.1080\/08870440290001494","journal-title":"Psychol Health"},{"key":"6929_CR12","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16065","volume":"11","author":"C \u00d6nder","year":"2023","unstructured":"\u00d6nder C, Bakirarar B (2023) Evaluating the Turkish validity and reliability of the brief illness perception questionnaire in periodontal diseases. PeerJ 11:e16065. https:\/\/doi.org\/10.7717\/peerj.16065","journal-title":"PeerJ"},{"issue":"6","key":"6929_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1037\/h0037562","volume":"42","author":"AT Beck","year":"1974","unstructured":"Beck AT, Weissman A, Lester D, Trexler L (1974) The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 42(6):861\u2013865. https:\/\/doi.org\/10.1037\/h0037562","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"6929_CR14","first-page":"134","volume":"1","author":"G Seber","year":"1993","unstructured":"Seber G, Dilbaz N, Kaptano\u011flu C, Tekin D (1993) Hopelessness scale: validity and reliability study. Kriz Derg 1(3):134\u2013138","journal-title":"Kriz Derg"},{"issue":"3","key":"6929_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jpepsy\/22.3.399","volume":"22","author":"CR Snyder","year":"1997","unstructured":"Snyder CR, Hoza B, Pelham WE, Rapoff M, Ware L, Danovsky M, Highberger L, Rubinstein H, Stahl KJ (1997) The development and validation of the children\u2019s hope scale. J Pediatr Psychol 22(3):399\u2013421. https:\/\/doi.org\/10.1093\/jpepsy\/22.3.399","journal-title":"J Pediatr Psychol"},{"key":"6929_CR16","unstructured":"Atik G, ve Kemer G (2009) \u00c7ocuklarda Umut \u00d6l\u00e7e\u011finin psikometrik \u00f6zellikleri: Ge\u00e7erlik ve g\u00fcvenirlik \u00e7al\u0131\u015fmas\u0131. \u0130lk\u00f6\u011fretim Online\u00a08(2):379\u2013390"},{"issue":"4","key":"6929_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1207\/S15327965PLI1304_01","volume":"13","author":"CR Snyder","year":"2002","unstructured":"Snyder CR (2002) Target article: hope theory: rainbows in the mind. Psychol Inq 13(4):249\u2013275. https:\/\/doi.org\/10.1207\/S15327965PLI1304_01","journal-title":"Psychol Inq"},{"issue":"6","key":"6929_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60(6):631\u2013637. https:\/\/doi.org\/10.1016\/j.jpsychores.2005.10.020","journal-title":"J Psychosom Res"},{"key":"6929_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2016.02022","volume":"7","author":"CC Schiavon","year":"2017","unstructured":"Schiavon CC, Marchetti E, Gurgel LG, Busnello FM, Reppold CT (2017) Optimism and hope in chronic disease: a systematic review. Front Psychol 7:2022. https:\/\/doi.org\/10.3389\/fpsyg.2016.02022","journal-title":"Front Psychol"},{"issue":"3","key":"6929_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4094\/chnr.2020.26.3.323","volume":"26","author":"A Mardhiyah","year":"2020","unstructured":"Mardhiyah A, Philip K, Mediani HS, Yosep I (2020) The association between hope and quality of life among adolescents with chronic diseases: a systematic review. Child Health Nurs Res 26(3):323\u2013328. https:\/\/doi.org\/10.4094\/chnr.2020.26.3.323","journal-title":"Child Health Nurs Res"},{"issue":"2","key":"6929_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpsychores.2010.06.005","volume":"70","author":"GS Sawicki","year":"2011","unstructured":"Sawicki GS, Sellers DE, Robinson WM (2011) Associations between illness perceptions and health-related quality of life in adults with cystic fibrosis. J Psychosom Res 70(2):161\u2013167. https:\/\/doi.org\/10.1016\/j.jpsychores.2010.06.005","journal-title":"J Psychosom Res"},{"key":"6929_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/088704403100081321","volume":"18","author":"M Hagger","year":"2003","unstructured":"Hagger M, Orbell S (2003) A meta-analytic review of the common-sense model of illness representations. Psychology & Health - PSYCHOL HEALTH 18:141\u2013184. https:\/\/doi.org\/10.1080\/088704403100081321","journal-title":"Psychology & Health - PSYCHOL HEALTH"},{"issue":"2","key":"6929_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/0033-2909.101.2.213","volume":"101","author":"TM Achenbach","year":"1987","unstructured":"Achenbach TM, McConaughy SH, Howell CT (1987) Child\/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull 101(2):213\u2013232","journal-title":"Psychol Bull"},{"issue":"4","key":"6929_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10578-008-0097-6","volume":"39","author":"S Dav\u00e9","year":"2008","unstructured":"Dav\u00e9 S, Nazareth I, Senior R, Sherr L (2008) A comparison of father and mother report of child behaviour on the Strengths and Difficulties Questionnaire. Child Psychiatry Hum Dev 39(4):399\u2013413. https:\/\/doi.org\/10.1007\/s10578-008-0097-6","journal-title":"Child Psychiatry Hum Dev"},{"issue":"6","key":"6929_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/children8060525","volume":"8","author":"E von Scheven","year":"2021","unstructured":"von Scheven E, Nahal BK, Kelekian R, Frenzel C, Vanderpoel V, Franck LS (2021) Getting to hope: perspectives from patients and caregivers living with chronic childhood illness. Children 8(6):525. https:\/\/doi.org\/10.3390\/children8060525","journal-title":"Children"},{"key":"6929_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pecinn.2024.100331","volume":"5","author":"E Zahl","year":"2024","unstructured":"Zahl E, Willemen AM, Fredriksen T et al (2024) Mental health in mothers and fathers of children with chronic disorders. PEC Innovation 5:100331. https:\/\/doi.org\/10.1016\/j.pecinn.2024.100331","journal-title":"PEC Innovation"},{"issue":"8","key":"6929_CR27","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.11124\/JBIES-21-00364","volume":"20","author":"FBP Befecadu","year":"2022","unstructured":"Befecadu FBP, Perrenoud B, Behaghel G et al (2022) Experience of hope in adult patients with advanced chronic disease and their informal caregivers: a qualitative systematic review protocol. JBI Evidence Synthesis 20(8):2025\u20132031. https:\/\/doi.org\/10.11124\/JBIES-21-00364","journal-title":"JBI Evidence Synthesis"},{"issue":"5","key":"6929_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ppul.25859","volume":"57","author":"E Kramer-Golinkoff","year":"2022","unstructured":"Kramer-Golinkoff E, Camacho A, Kramer L, Taylor-Cousar JL (2022) A survey: understanding the health and perspectives of people with CF not benefiting from CFTR modulators. Pediatr Pulmonol 57(5):1253\u20131261. https:\/\/doi.org\/10.1002\/ppul.25859","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"6929_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.71037","volume":"60","author":"B Uzunoglu","year":"2025","unstructured":"Uzunoglu B, Selcuk Balci M, Kalyoncu M et al (2025) Elexacaftor\/tezacaftor\/ivacaftor treatment accessibility and mental health: reducing anxiety in people with cystic fibrosis. Pediatr Pulmonol 60(3):e71037. https:\/\/doi.org\/10.1002\/ppul.71037","journal-title":"Pediatr Pulmonol"},{"key":"6929_CR30","unstructured":"Zolin A, Adamoli A, Bakkeheim E, et al (2025) ECFSPR Annual Highlights Report 2023. European Cystic Fibrosis Society Patient Registry"},{"key":"6929_CR31","doi-asserted-by":"publisher","unstructured":"Burgel PR, Sermet-Gaudelus I, Girodon E, et al (2024) The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study [published correction appears in Lancet Respir Med 12(11):e70. https:\/\/doi.org\/10.1016\/S2213-2600(24)00333-3.].\u00a0Lancet Respir Med. 2024;12(11):888\u2013900. https:\/\/doi.org\/10.1016\/S2213-2600(24)00208-X","DOI":"10.1016\/S2213-2600(24)00333-3"},{"issue":"4","key":"6929_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jcf.2024.02.006","volume":"23","author":"H Bihler","year":"2024","unstructured":"Bihler H, Sivachenko A, Millen L et al (2024) In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis. J Cyst Fibros 23(4):664\u2013675. https:\/\/doi.org\/10.1016\/j.jcf.2024.02.006","journal-title":"J Cyst Fibros"},{"issue":"6","key":"6929_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/17476348.2021.1855980","volume":"15","author":"PG Middleton","year":"2021","unstructured":"Middleton PG, Taylor-Cousar JL (2021) Development of elexacaftor - tezacaftor - ivacaftor: highly effective CFTR modulation for the majority of people with Cystic Fibrosis. Expert Rev Respir Med 15(6):723\u2013735. https:\/\/doi.org\/10.1080\/17476348.2021.1855980","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"6929_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002606","volume":"12","author":"M Harrigan","year":"2025","unstructured":"Harrigan M, Georgiopoulos AM, Quittner AL, Smith B, Douglas TA (2025) Psychosocial and mental health in cystic fibrosis in the modern era of care: time to evolve. BMJ Open Respir Res 12(1):e002606. https:\/\/doi.org\/10.1136\/bmjresp-2024-002606","journal-title":"BMJ Open Respir Res"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06929-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06929-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:25Z","timestamp":1780120945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06929-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6929"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06929-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Ethics Committee of Istanbul University\u2013Cerrahpa\u015fa, Cerrahpa\u015fa Medical Faculty (Decision No: 1078897 dated 02.09.2024). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants and from the parents or legal guardians of the children included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"266"}}